The Minibrain (Mnb) gene is mapped to the Down syndrome critical region of human chromosome 21. Evidence suggests that an elevated Mnb gene dosage, as in trisomy 21, contributes to Down syndrome phenotypes. The Mnb encodes a dual specificity protein kinase whose cellular function has yet to be determined. Our preliminary results suggest that MnB kinase is involved in controlling the activity of dynamin-1, while its enzymatic activity is in turn regulated by rabaptin-5 and a novel cysteine-rich protein. Since both dynamin-1 and rabaptin-5 are part of endocytosis machinery, it also suggests that the Mnb kinase must play an essential role in regulating endocytic membrane trafficking. We plan to pursue the following specific aims in this study: 1. To establish the Mnb kinase as the enzyme responsible for regulating dynamin-1 physiological activity through phosphorylation. 2. To determine the mechanisms of regulating the enzymatic activity of Mnb kinase by rabaptin-5 and the cysteine-rich protein. 3. To characterize the biochemical properties of dynamin-12 phosphorylated by Mnb kinase. 4. To study the effects of Mnb kinase over-expression on endocytic membrane trafficking.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD038295-03
Application #
6521258
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Oster-Granite, Mary Lou
Project Start
2000-03-01
Project End
2005-02-28
Budget Start
2002-03-01
Budget End
2003-02-28
Support Year
3
Fiscal Year
2002
Total Cost
$218,181
Indirect Cost
Name
Institute for Basic Research in Dev Disabil
Department
Type
DUNS #
167205090
City
Staten Island
State
NY
Country
United States
Zip Code
10314
Wegiel, Jerzy; Gong, Cheng-Xin; Hwang, Yu-Wen (2011) The role of DYRK1A in neurodegenerative diseases. FEBS J 278:236-45
Liu, Fei; Liang, Zhihou; Wegiel, Jerzy et al. (2008) Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome. FASEB J 22:3224-33
Wegiel, Jerzy; Dowjat, Karol; Kaczmarski, Wojciech et al. (2008) The role of overexpressed DYRK1A protein in the early onset of neurofibrillary degeneration in Down syndrome. Acta Neuropathol 116:391-407
Xie, Wen; Ramakrishna, Narayan; Wieraszko, Andrzej et al. (2008) Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate. Neurochem Res 33:776-83
Dowjat, Wieslaw K; Adayev, Tatyana; Kuchna, Izabela et al. (2007) Trisomy-driven overexpression of DYRK1A kinase in the brain of subjects with Down syndrome. Neurosci Lett 413:77-81
Adayev, Tatyana; Chen-Hwang, Mo-Chou; Murakami, Noriko et al. (2007) Dual-specificity tyrosine phosphorylation-regulated kinase 1A does not require tyrosine phosphorylation for activity in vitro. Biochemistry 46:7614-24
Adayev, Tatyana; Chen-Hwang, Mo-Chou; Murakami, Noriko et al. (2006) Kinetic properties of a MNB/DYRK1A mutant suitable for the elucidation of biochemical pathways. Biochemistry 45:12011-9
Adayev, Tatyana; Chen-Hwang, Mo-Chou; Murakami, Noriko et al. (2006) MNB/DYRK1A phosphorylation regulates the interactions of synaptojanin 1 with endocytic accessory proteins. Biochem Biophys Res Commun 351:1060-5
Murakami, Noriko; Xie, Wen; Lu, Renne Chen et al. (2006) Phosphorylation of amphiphysin I by minibrain kinase/dual-specificity tyrosine phosphorylation-regulated kinase, a kinase implicated in Down syndrome. J Biol Chem 281:23712-24
Antony, Ayyok; Tang, Ying-Sheng; Khan, Rehana A et al. (2004) Translational upregulation of folate receptors is mediated by homocysteine via RNA-heterogeneous nuclear ribonucleoprotein E1 interactions. J Clin Invest 113:285-301

Showing the most recent 10 out of 14 publications